| Literature DB >> 32113147 |
Floor N H Wilting1, Marijn Hameeteman2, Hanneke J P Tielemans2, Dietmar J O Ulrich2, Stefan Hummelink2.
Abstract
OBJECTIVES: To date, little is known about postoperative changes in breast volume after autologous breast reconstruction. The purpose of this retrospective study was to investigate breast volume changes following autologous free flap reconstruction and the factors affecting flap volume.Entities:
Keywords: 3D imaging; 3D stereophotogrammetry; Autologous reconstruction; Breast reconstruction; Free flap; Volume change
Mesh:
Year: 2020 PMID: 32113147 PMCID: PMC7380344 DOI: 10.1016/j.breast.2020.02.005
Source DB: PubMed Journal: Breast ISSN: 0960-9776 Impact factor: 4.380
Fig. 1Breast volume measurement. (A) The boundaries of the breasts are selected, (B) The breast volume is measured.
Fig. 2Flow chart of breast inclusion.
Patient characteristics at time of reconstruction.
| Patient characteristic | Value | |
|---|---|---|
| Sample size; n | 101 | |
| Age; mean ± SD (years) | 49.1 | ±10.4 |
| BMI; mean ± SD (kg/m2) | 26.65 | ±2.41 |
| Laterality; n (%) | ||
| Unilateral | 57 | (56.4%) |
| Bilateral | 44 | (43.5%) |
| Smoking status; n (%) | ||
| Nonsmoker | 58 | (57.4%) |
| Ex-smoker | 40 | (39.6%) |
| Current smoker | 3 | (3.0%) |
| Systemic (neo)adjuvant treatment; n (%) | ||
| No systemic (neo)adjuvant treatment | 33 | (32.6%) |
| Chemotherapy only | 15 | (14.9%) |
| Hormonal therapy only | 3 | (3.0%) |
| Chemotherapy and hormonal therapy | 50 | (49.5%) |
| High-risk genetic mutation; n (%) | ||
| High-risk mutation | 28 | (27.7%) |
| No mutation | 25 | (24.8%) |
| Unknown (not tested) | 47 | (46.5%) |
In 9 patients, one of two reconstructed breasts is excluded.
Defined as actively smoking at the time of, quitting smoking <3 months prior to and/or restarting smoking after reconstruction.
BRCA1, BRCA2 and CHEK2 mutation.
Reconstructed breast characteristics.
| Breast characteristic | Value | |
|---|---|---|
| Sample size; n | 136 | |
| Ischemia time; mean ± SD (minutes) | 58.9 | ±23.7 |
| Breast side; n (%) | ||
| Left | 64 | (47.1%) |
| Right | 72 | (52.9%) |
| Reconstruction type; n (%) | ||
| DIEP | 124 | (91.1%) |
| SIEA | 2 | (1.5%) |
| PAP | 10 | (7.4%) |
| Timing; n (%) | ||
| Primary | 49 | (36.0%) |
| Secondary | 65 | (47.8%) |
| Tertiary | 22 | (16.2%) |
| Reason for mastectomy; n | ||
| In situ or invasive breast cancer | 77 | (56.6%) |
| Prophylactic | 53 | (39.0%) |
| Prophylactic after lumpectomy | 6 | (4.4%) |
| Radiation before reconstruction; n (%) | 52 | (38.2%) |
| Axillary lymph node dissection; n (%) | 36 | (26.5%) |
| Reconstruction combined with LNT | 22 | (16.2%) |
LNT = lymph node transplantation.
126 breasts (in 10 cases ischemia time unknown).
Nested mixed effects model (model 1).
| β-value | LCI | UCI | p-value | |||
|---|---|---|---|---|---|---|
| Intercept | 561.803 | 518.290 | 605.315 | <0.001 | *** | |
| x | 16.650 | −12.882 | 46.181 | 0.268 | ||
| x2 | 37.617 | 21.529 | 53.706 | <0.001 | *** | |
| x3 | −40.270 | −60.876 | −19.664 | <0.001 | *** | |
| x4 | 8.374 | 3.350 | 13.398 | 0.001 | ** | |
Standardized time variable (x) = .
LCI = lower confidential interval, UCI = upper confidential interval.
p-values <0.05 = *, p < 0.01 = ** and p < 0.001 = ***.
Fig. 3Predicted population average of breast volume change over six months (with 95% confidential interval) following autologous free flap reconstruction.
Univariable nested mixed-effects model (model 2). Regression coefficients not shown; complete overview is included in Supplemental Digital Content.
| Variable | β-value | LCI | UCI | p-value | ||
|---|---|---|---|---|---|---|
| Age | 1.711 | −2.543 | 5.964 | 0.427 | ||
| Age x | 0.863 | −2.230 | 3.957 | 0.583 | ||
| Age x2 | −0.471 | −1.936 | 0.995 | 0.527 | ||
| Age x3 | 0.346 | −1.783 | 0.274 | 0.749 | ||
| Age x4 | −0.098 | −0.609 | 0.412 | 0.705 | ||
| BMIa | 55.219 | 40.680 | 69.757 | <0.001 | *** | |
| BMI x | 11.367 | −0.639 | 23.372 | 0.063 | ||
| BMI x2 | 1.726 | −4.877 | 8.330 | 0.607 | ||
| BMI x3 | −4.472 | −12.976 | 4.032 | 0.301 | ||
| BMI x4 | 0.717 | −1.581 | 3.015 | 0.539 | ||
| Autologous technique | −335.208 | −506.741 | −163.675 | <0.001 | *** | |
| Autologous technique x | −162.118 | −340.667 | 16.432 | 0.075 | ||
| Autologous technique x2 | 27.099 | −49.056 | 103.255 | 0.484 | ||
| Autologous technique x3 | 87.427 | −34.411 | 209.264 | 0.159 | ||
| Autologous technique x4 | −25.185 | −63.414 | 13.045 | 0.196 | ||
| Timing | −86.970 | −164.185 | −9.755 | 0.029 | * | |
| Timing x | 29.211 | −31.561 | 89.983 | 0.344 | ||
| Timing x2 | −46.830 | −79.294 | −14.366 | 0.005 | ** | |
| Timing x3 | 16.245 | −25.994 | 58.484 | 0.449 | ||
| Timing x4 | −1.963 | −12.310 | 8.384 | 0.709 | ||
| Indication | −25.945 | −85.300 | 33.410 | 0.381 | ||
| Indication x | 6.708 | −51.688 | 65.104 | 0.821 | ||
| Indication x2 | −55.334 | −85.194 | −21.473 | 0.001 | ** | |
| Indication x3 | 33.606 | −7.520 | 74.731 | 0.109 | ||
| Indication x4 | −5.942 | −16.097 | 4.212 | 0.250 | ||
| First PO breast volume | 0.845 | 0.763 | 0.926 | <0.001 | *** | |
| First PO breast volume x | 0.118 | −0.056 | 0.261 | 0.107 | ||
| First PO breast volume x2 | 0.127 | 0.0476 | 0.207 | 0.002 | ** | |
| First PO breast volume x3 | −0.120 | −0.229 | −0.010 | 0.032 | * | |
| First PO breast volume x4 | 0.019 | −0.016 | 0.055 | 0.282 | ||
| Ischemia time | −1.243 | −2.848 | 0.362 | 0.125 | ||
| Ischemia time x | −0.445 | −2.136 | 1.247 | 0.605 | ||
| Ischemia time x2 | 0.121 | −0.754 | 0.996 | 0.786 | ||
| Ischemia time x3 | 0.324 | −0.961 | 1.610 | 0.619 | ||
| Ischemia time x4 | −0.173 | −0.672 | 0.326 | 0.496 | ||
| Radiotherapy | −35.544 | −101.990 | 30.902 | 0.285 | ||
| Radiotherapy x | −8.644 | −70.750 | 53.462 | 0.784 | ||
| Radiotherapy x2 | −26.595 | −59.237 | 6.047 | 0.110 | ||
| Radiotherapy x3 | 29.198 | −14.742 | 73.139 | 0.192 | ||
| Radiotherapy x4 | −6.823 | −17.978 | 4.332 | 0.229 | ||
Standardized time variable (x) = .
PO = postoperative, LCI = lower confidential interval, UCI = upper confidential interval.
p-values <0.05 = *, p < 0.01 = ** and p < 0.001 = ***.
Continuous variables: age, BMI, first PO breast volume and ischemia time.
Binary variables (0 vs. 1): autologous technique = abdominal vs. PAP flap; timing = primary vs. secondary + tertiary; indication = prophylactic vs. breast cancer, radiotherapy = no vs. yes.
Fig. 4Predicted population average of breast volume change over six months for different variables. (A) BMI, (B) autologous technique, (C) reconstruction timing, (D) mastectomy indication, (E) first postoperatively (PO) measured breast volume.